An agentic research shop
Biotech research consultant. Every figure sourced.
For investors, pharma business development, university technology transfer and founders, I take on the question you would otherwise brief a large firm on -- a deal to weigh, a technology to value, a product to carry to market, a research run on your own problem -- from the raw record, with every figure traced to its source.
- I read two seed-stage decks for an angel group against the primary record and delivered both in six days; two patents one deck called issued were found expired. ->
- Seven oncology readouts, called before the data and scored in public, misses included. ->
Twenty years in biotech: assay development at Novartis, product strategy at Shire, then a company I founded in 2017 on a Caltech imaging licence that sold its first instrument to a Fortune 100 pharma. About 25 deals by hand since 2015, about 100 reports through the pipeline, one delivered to a medtech client. About ->
Examples of work
- Conjugation technology landscape: workbook and board pack for a biotech operator.
- Early-stage investment workup: cap table, bottom-up market size, pricing, exit comparables, term-sheet redline, data-room punch list.
- Pre-registered clinical readout call with a price target and an invalidation level, sealed before the data.
- Briefing book answering a prospect's own questions: PDF, deck and tables.
- University invention commercialization assessment with an editable market model, benchmarked against a paid consultant.
- Target product profile, commercial and clinical-trial labels, device profile and pre-submission inputs for a surgical device, from 22 interviews with surgeons, nurses, patients and buyers, and a surgery observed.
- Translation and verification of a government industry plan, every number and negation matched to the source characters.
What you can hire
A biotech research consultant answers one question a client cannot staff from inside -- is this deal sound, what is this technology worth, how does this product reach market, what does the record say -- and hands back a document that shows its sources.
Diligence and landscapes
Investors, angel groups and pharma business development weighing a deal, an asset or a field.
A read built from filings, trial registries, patents and the literature, with a dated call where the evidence supports one and every figure two clicks from its source.
A conjugation technology landscape, delivered as a workbook and a board pack, for a biotech operator.
Commercialization assessments
University technology-transfer offices, inventors and founders deciding what a technology is worth and who would buy it.
An assessment built as a decision: the recommendation on page one, a source ledger, and the market model as an editable spreadsheet, so you can change an assumption and watch the answer move.
A university invention assessed under a CDA and benchmarked head to head against a paid consultant's report and a commercial report vendor's, on the same input.
Founder operating jobs
Early biotech and medtech founders who need an operator for a bounded job: a licence, a round, a grant, a product definition.
Hands-on work from someone who has carried a product from a university licence to a first commercial sale.
I founded Mango in 2017, licensed a Caltech imaging technology, built it into a commercial sterility-testing instrument and ran its pre-seed round; the company still sells on that platform in 2026.
The research engine
Pharma teams and research groups who want the same pipeline run on their own question.
A multi-step run -- ingest, collect, verify, write, adversarial review, revise, audit -- across about 2,724 primary-database tools, with a fact engine that admits a claim only with a verbatim source.
Start here
- Calibration -- what a readout is worth
Seven oncology readouts, called before the data and scored in public, misses included.
Hiring a biotech consultant
Biotech consulting is outside help on one question a company cannot staff from inside: a deal to weigh, a technology to value, a product to carry to market, a question to research from the record. A biotech consultant reads the primary record behind that question and hands back a written answer that shows its sources. What it costs to hire one here: the scope and the fee are fixed in writing before any work starts, there is no hourly billing, and I do not publish rates, so the first step is the call below.